Personal information

No personal information available

Activities

Collapse all

Employment (2)

Dana-Farber Cancer Institute: Boston, MA, US

2021-12-06 to present | Research Fellow (Medical Oncology)
Employment
Source: Self-asserted source
Yuqing Zhang

University of Texas Southwestern Medical Center: Dallas, TX, US

2017-03 to 2021-11-14 (Department of Surgery)
Employment
Source: Self-asserted source
Yuqing Zhang

Education and qualifications (2)

University of Texas Southwestern Medical Center: Dallas, TX, US

2016-08 to 2021-11 | Ph.D. (Cancer Biology)
Education
Source: Self-asserted source
Yuqing Zhang

Sun Yat-Sen University: Guangzhou, Guangdong, CN

2012-09 to 2016-06
Education
Source: Self-asserted source
Yuqing Zhang

Works (11)

Data from AXL Inhibitor TP-0903 Reduces Metastasis and Therapy Resistance in Pancreatic Cancer

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.c.6543388.v1
Contributors: Yuqing Zhang; Emily N. Arner; Ali Rizvi; Jason E. Toombs; Huocong Huang; Steven L. Warner; Jason M. Foulks; Rolf A. Brekken
Source: check_circle
Crossref

Data from AXL Inhibitor TP-0903 Reduces Metastasis and Therapy Resistance in Pancreatic Cancer

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.c.6543388
Contributors: Yuqing Zhang; Emily N. Arner; Ali Rizvi; Jason E. Toombs; Huocong Huang; Steven L. Warner; Jason M. Foulks; Rolf A. Brekken
Source: check_circle
Crossref

Supplementary figures and legends from AXL Inhibitor TP-0903 Reduces Metastasis and Therapy Resistance in Pancreatic Cancer

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522456
Contributors: Yuqing Zhang; Emily N. Arner; Ali Rizvi; Jason E. Toombs; Huocong Huang; Steven L. Warner; Jason M. Foulks; Rolf A. Brekken
Source: check_circle
Crossref

Supplementary figures and legends from AXL Inhibitor TP-0903 Reduces Metastasis and Therapy Resistance in Pancreatic Cancer

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522456.v1
Contributors: Yuqing Zhang; Emily N. Arner; Ali Rizvi; Jason E. Toombs; Huocong Huang; Steven L. Warner; Jason M. Foulks; Rolf A. Brekken
Source: check_circle
Crossref

Are TEMs Canceled? Questioning the Functional Relevance of Tie2-Expressing Macrophages

Cancer Research
2022-04-01 | Journal article
DOI: 10.1158/0008-5472.CAN-22-0330
Contributors: Yuqing Zhang; Rolf A. Brekken
Source: check_circle
Crossref

AXL Inhibitor TP-0903 Reduces Metastasis and Therapy Resistance in Pancreatic Cancer

Molecular Cancer Therapeutics
2022-01-01 | Journal article
DOI: 10.1158/1535-7163.MCT-21-0293
Contributors: Yuqing Zhang; Emily N. Arner; Ali Rizvi; Jason E. Toombs; Huocong Huang; Steven L. Warner; Jason M. Foulks; Rolf A. Brekken
Source: check_circle
Crossref

VEGFR2 activity on myeloid cells mediates immune suppression in the tumor microenvironment

JCI Insight
2021-12-08 | Journal article
DOI: 10.1172/jci.insight.150735
Contributors: Yuqing Zhang; Huocong Huang; Morgan Coleman; Arturas Ziemys; Purva Gopal; Syed M. Kazmi; Rolf A. Brekken
Source: check_circle
Crossref

Perspectives on Hypoxia Signaling in Tumor Stroma

Cancers
2021-06-20 | Journal article
DOI: 10.3390/cancers13123070
Contributors: Yuqing Zhang; Morgan Coleman; Rolf A. Brekken
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Targeting TGF βR2‐mutant tumors exposes vulnerabilities to stromal TGF β blockade in pancreatic cancer

EMBO Molecular Medicine
2019-11-07 | Journal article
DOI: 10.15252/emmm.201910515
Contributors: Huocong Huang; Yuqing Zhang; Valerie Gallegos; Noah Sorrelle; Mohamed Medhat Zaid; Jason Toombs; Wenting Du; Steven Wright; Moriah Hagopian; Zhaoning Wang et al.
Source: check_circle
Crossref

Improved Multiplex Immunohistochemistry for Immune Microenvironment Evaluation of Mouse Formalin-Fixed, Paraffin-Embedded Tissues.

Journal of immunology (Baltimore, Md. : 1950)
2018-12-03 | Journal article
DOI: 10.4049/jimmunol.1800878
PMID: 30510069
PMC: PMC6310091
Source: Self-asserted source
Yuqing Zhang

Cyclooxygenase-2 Inhibition Potentiates the Efficacy of Vascular Endothelial Growth Factor Blockade and Promotes an Immune Stimulatory Microenvironment in Preclinical Models of Pancreatic Cancer.

Molecular cancer research : MCR
2018-10-17 | Journal article
DOI: 10.1158/1541-7786.mcr-18-0427
PMID: 30333153
PMC: PMC6359969
Source: Self-asserted source
Yuqing Zhang

Peer review (3 reviews for 2 publications/grants)

Review activity for Cancers. (2)
Review activity for Journal of clinical medicine. (1)
How many people are using ORCID?